Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections

Pavan Puligujja, JoEllyn M McMillan, Lindsey Kendrick, Tianyuzi Li, Shantanu Balkundi, Nathan Smith, Ram S. Veerubhotla, Benson J Edagwa, Alexander V. Kabanov, Tatiana K Bronich, Howard Eliot Gendelman, Xin Ming Liu

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Macrophages serve as vehicles for the carriage and delivery of polymer-coated nanoformulated antiretroviral therapy (nanoART). Although superior to native drug, high drug concentrations are required for viral inhibition. Herein, folate-modified ritonavir-boosted atazanavir (ATV/r)-encased polymers facilitated macrophage receptor targeting for optimizing drug dosing. Folate coating of nanoART ATV/r significantly enhanced cell uptake, retention and antiretroviral activities without altering cell viability. Enhanced retentions of folate-coated nanoART within recycling endosomes provided a stable subcellular drug depot. Importantly, up to a five-fold enhanced plasma and tissue drug levels followed folate-coated formulation injection in mice. Folate polymer encased ATV/r improves nanoART pharmacokinetics bringing the technology one step closer to human use. From the Clinical Editor: This team of authors describes a novel method for macrophage folate receptor-targeted antiretroviral therapy. Atazanvir entry, retention, and antiretroviral activities were superior using the presented method, and so was its biodistribution, enabling a more efficient way to address human immunodeficiency virus infections, with a hoped for clinical application in the near future.

Original languageEnglish (US)
Pages (from-to)1263-1273
Number of pages11
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume9
Issue number8
DOIs
StatePublished - Nov 1 2013

Fingerprint

Drug therapy
Macrophages
Virus Diseases
Viruses
Folic Acid
HIV
Drug Therapy
Polymers
Pharmacokinetics
Pharmaceutical Preparations
Recycling
Cells
Tissue
Plasmas
Therapeutics
Ritonavir
Coatings
Endosomes
Drug Delivery Systems
Cell Survival

Keywords

  • ATV/r
  • Folate
  • Human immunodeficiency virus
  • Macrophages
  • NanoART
  • Poloxamer 407
  • Targeted drug delivery

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biomedical Engineering
  • Materials Science(all)
  • Pharmaceutical Science

Cite this

Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections. / Puligujja, Pavan; McMillan, JoEllyn M; Kendrick, Lindsey; Li, Tianyuzi; Balkundi, Shantanu; Smith, Nathan; Veerubhotla, Ram S.; Edagwa, Benson J; Kabanov, Alexander V.; Bronich, Tatiana K; Gendelman, Howard Eliot; Liu, Xin Ming.

In: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 9, No. 8, 01.11.2013, p. 1263-1273.

Research output: Contribution to journalArticle

@article{a6437aab95cc45ef80fb488414a9a501,
title = "Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections",
abstract = "Macrophages serve as vehicles for the carriage and delivery of polymer-coated nanoformulated antiretroviral therapy (nanoART). Although superior to native drug, high drug concentrations are required for viral inhibition. Herein, folate-modified ritonavir-boosted atazanavir (ATV/r)-encased polymers facilitated macrophage receptor targeting for optimizing drug dosing. Folate coating of nanoART ATV/r significantly enhanced cell uptake, retention and antiretroviral activities without altering cell viability. Enhanced retentions of folate-coated nanoART within recycling endosomes provided a stable subcellular drug depot. Importantly, up to a five-fold enhanced plasma and tissue drug levels followed folate-coated formulation injection in mice. Folate polymer encased ATV/r improves nanoART pharmacokinetics bringing the technology one step closer to human use. From the Clinical Editor: This team of authors describes a novel method for macrophage folate receptor-targeted antiretroviral therapy. Atazanvir entry, retention, and antiretroviral activities were superior using the presented method, and so was its biodistribution, enabling a more efficient way to address human immunodeficiency virus infections, with a hoped for clinical application in the near future.",
keywords = "ATV/r, Folate, Human immunodeficiency virus, Macrophages, NanoART, Poloxamer 407, Targeted drug delivery",
author = "Pavan Puligujja and McMillan, {JoEllyn M} and Lindsey Kendrick and Tianyuzi Li and Shantanu Balkundi and Nathan Smith and Veerubhotla, {Ram S.} and Edagwa, {Benson J} and Kabanov, {Alexander V.} and Bronich, {Tatiana K} and Gendelman, {Howard Eliot} and Liu, {Xin Ming}",
year = "2013",
month = "11",
day = "1",
doi = "10.1016/j.nano.2013.05.003",
language = "English (US)",
volume = "9",
pages = "1263--1273",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections

AU - Puligujja, Pavan

AU - McMillan, JoEllyn M

AU - Kendrick, Lindsey

AU - Li, Tianyuzi

AU - Balkundi, Shantanu

AU - Smith, Nathan

AU - Veerubhotla, Ram S.

AU - Edagwa, Benson J

AU - Kabanov, Alexander V.

AU - Bronich, Tatiana K

AU - Gendelman, Howard Eliot

AU - Liu, Xin Ming

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Macrophages serve as vehicles for the carriage and delivery of polymer-coated nanoformulated antiretroviral therapy (nanoART). Although superior to native drug, high drug concentrations are required for viral inhibition. Herein, folate-modified ritonavir-boosted atazanavir (ATV/r)-encased polymers facilitated macrophage receptor targeting for optimizing drug dosing. Folate coating of nanoART ATV/r significantly enhanced cell uptake, retention and antiretroviral activities without altering cell viability. Enhanced retentions of folate-coated nanoART within recycling endosomes provided a stable subcellular drug depot. Importantly, up to a five-fold enhanced plasma and tissue drug levels followed folate-coated formulation injection in mice. Folate polymer encased ATV/r improves nanoART pharmacokinetics bringing the technology one step closer to human use. From the Clinical Editor: This team of authors describes a novel method for macrophage folate receptor-targeted antiretroviral therapy. Atazanvir entry, retention, and antiretroviral activities were superior using the presented method, and so was its biodistribution, enabling a more efficient way to address human immunodeficiency virus infections, with a hoped for clinical application in the near future.

AB - Macrophages serve as vehicles for the carriage and delivery of polymer-coated nanoformulated antiretroviral therapy (nanoART). Although superior to native drug, high drug concentrations are required for viral inhibition. Herein, folate-modified ritonavir-boosted atazanavir (ATV/r)-encased polymers facilitated macrophage receptor targeting for optimizing drug dosing. Folate coating of nanoART ATV/r significantly enhanced cell uptake, retention and antiretroviral activities without altering cell viability. Enhanced retentions of folate-coated nanoART within recycling endosomes provided a stable subcellular drug depot. Importantly, up to a five-fold enhanced plasma and tissue drug levels followed folate-coated formulation injection in mice. Folate polymer encased ATV/r improves nanoART pharmacokinetics bringing the technology one step closer to human use. From the Clinical Editor: This team of authors describes a novel method for macrophage folate receptor-targeted antiretroviral therapy. Atazanvir entry, retention, and antiretroviral activities were superior using the presented method, and so was its biodistribution, enabling a more efficient way to address human immunodeficiency virus infections, with a hoped for clinical application in the near future.

KW - ATV/r

KW - Folate

KW - Human immunodeficiency virus

KW - Macrophages

KW - NanoART

KW - Poloxamer 407

KW - Targeted drug delivery

UR - http://www.scopus.com/inward/record.url?scp=84886436130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886436130&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2013.05.003

DO - 10.1016/j.nano.2013.05.003

M3 - Article

VL - 9

SP - 1263

EP - 1273

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

SN - 1549-9634

IS - 8

ER -